title: Sequencing and combining systemic therapies for pancreatic neuroendocrine tumors.
authors: Program in Neuroendocrine and Carcinoid Tumors, Dana-Farber Cancer Institute, Boston, MA matthew_kulke@dfci.harvard.edu.
authors: Matthew H
authors: MH
authors: Kulke
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis; D003967:Diarrhea / Q000209:etiology; D004334:Drug Administration Schedule; D000068338:Everolimus; D006801:Humans; D007211:Indoles / Q000008:administration & dosage; D019394:Ki-67 Antigen / Q000032:analysis; D008113:Liver Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000556:secondary; D008297:Male; D008875:Middle Aged; D008940:Mitotic Index; D060787:Neoplasm Grading; D018358:Neuroendocrine Tumors / Q000150:complications / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000378:metabolism; D010190:Pancreatic Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000378:metabolism; D011758:Pyrroles / Q000008:administration & dosage; D020123:Sirolimus / Q000008:administration & dosage / Q000031:analogs & derivatives; D013004:Somatostatin / Q000031:analogs & derivatives / Q000627:therapeutic use*; D000077210:Sunitinib; D014057:Tomography, X-Ray Computed
chemical_list: D014408:Biomarkers, Tumor; D007211:Indoles; D019394:Ki-67 Antigen; D011758:Pyrroles; D013004:Somatostatin; D000068338:Everolimus; D000077210:Sunitinib; D020123:Sirolimus